主观认知衰退进展的风险因素和认知领域标志物
medRxiv : the preprint server for health sciences
|September 4, 2024
概括
低教育程度,西班牙裔种族和高胆固醇血症是主观认知衰退 (SCD) 进展的关键风险因素. 这些因素,而不是APOE状态,预测风险人群的认知能力下降.
科学领域:
- 神经学 神经学
- 认知科学 认知科学
- 老年学是一门学科.
背景情况:
- 主观认知衰退 (SCD) 是认知障碍的早期阶段.
- 识别SCD进展的风险因素对于早期干预至关重要.
- 了解SCD的认知领域变化对于跟踪疾病轨迹至关重要.
研究的目的:
- 为了确定与SCD进展相关的风险因素差异.
- 检查与SCD进展相关的认知领域标记物.
- 为了比较稳定SCD的个体与那些进展到轻度认知障碍或更严重的人.
主要方法:
- 纵向研究设计包括SCD非衰减者和衰减者.
- 调整混合效应模型以分析人口统计,遗传 (APOE),心理测量和并发症数据.
- 评估认知领域,包括记忆,执行功能和语言.
主要成果:
- 较低的教育程度,西班牙裔种族和高胆固醇血症是SCD进展的显著风险因素 (p ≤0.05).
- 没有发现APOE状态是进展的重要风险因素.
- SCD下降者在记忆,执行和语言领域显著下降 (p < 0.001).
结论:
- 可修改的风险因素,如高胆固醇血症和教育程度影响SCD的进展.
- 针对这些可修改的因素,可能会为认知能力下降提供预防策略.
- 结果支持进一步研究SCD结果,生物标志物和有针对性的干预措施.
相关概念视频
Cognitive Development During Adulthood
72
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
72
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
Negative and Cognitive Symptoms of Schizophrenia
46
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
46
Cognitivism
1.4K
Cognitive psychology emerged as a significant field in the mid-20th century. It focused on understanding humans' internal mental processes. This approach emphasizes how people perceive, remember, think, and solve problems—elements critical to human cognition.
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process...
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process...
1.4K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
110
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
110


